Table 1 Demographic and psychometric data.

From: Structural and functional retinal alterations in patients with paranoid schizophrenia

Characteristic

HC N = 25

Patients N = 25

p-value

Sex (female/male)

15/10

15/10

>0.9a

Age in years

37 (12)

39 (12)

0.8

Smoking status (smoker/nonsmoker)

13/12

13/12

>0.9a

Duration of illness in years

 

9 (8)

 

Medication (unmedicated/medicated)

 

2/23

 

Neuroleptic medication (typical/atypical)

 

1/23

 

CPZ-equivalent dose in mg

 

355 (271)

 

PANSS-total

 

68 (15)

 

PANSS-P

 

14 (4)

 

PANSS-N

 

18 (5)

 

PANSS-G

 

35 (8)

 

CGI-S

 

4 (1)

 

GAF

 

46 (15)

 
  1. The number of observations is depicted for categorial data; numerical data are summarized by the mean and standard deviation (SD).
  2. CGI Clinical Global Impression Scale, CPZ chlorpromazin, HC healthy controls, GAF Global Assessment of Functioning, N number, PANSS Positive and Negative Syndrome Scale, PANSS-G Positive and Negative Syndrome Scale—General Psychopathology Scale, PANSS-N Positive and Negative Syndrome Scale—Negative Scale, PANSS-P Positive and Negative Syndrome Scale—Positive Scale.
  3. Comparisons: Wilcoxon and aFisher exact tests.
Back to article page